Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diego Sepulveda-Falla

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Neuron|February 28, 2024
Single-nucleus RNA sequencing demonstrates an autosomal dominant Alzheimer's disease profile and possible mechanisms of disease protectionMaria Camila Almeida, Sarah J Eger, Caroline He, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersVincent Malotaux, David Fernando Aguillón Niño, Isabela Gonzalez, et al.
JAMA|July 30, 2020
Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative DisordersSebastian Palmqvist, Shorena Janelidze, Yakeel T Quiroz, et al.
The American Journal of Pathology|April 24, 2021
Targeting Runt-Related Transcription Factor 1 Prevents Pulmonary Fibrosis and Reduces Expression of Severe Acute Respiratory Syndrome Coronavirus 2 Host MediatorsMichael O'Hare, Dhanesh Amarnani, Hannah A B Whitmore, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 4, 2023
APOE Christchurch-mimetic therapeutic antibody reduces APOE-mediated toxicity and tau phosphorylationClaudia Marino, Paula Perez-Corredor, Michael O'Hare, et al.
The Lancet. Neurology|May 30, 2020
Plasma neurofilament light chain in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional and longitudinal cohort studyYakeel T Quiroz, Henrik Zetterberg, Eric M Reiman, et al.
Acta Neuropathologica|July 15, 2022
Distinct tau neuropathology and cellular profiles of an APOE3 Christchurch homozygote protected against autosomal dominant Alzheimer's dementiaDiego Sepulveda-Falla, Justin S Sanchez, Maria Camila Almeida, et al.
The New England Journal of Medicine|June 20, 2024
<i>APOE3</i> Christchurch Heterozygosity and Autosomal Dominant Alzheimer's DiseaseYakeel T Quiroz, David Aguillon, Daniel C Aguirre-Acevedo, et al.
Stem Cell Reports|January 22, 2022
The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2Susanne Krasemann, Undine Haferkamp, Susanne Pfefferle, et al.
Acta Neuropathologica|July 9, 2024
Cleavage site-directed antibodies reveal the prion protein in humans is shed by ADAM10 at Y226 and associates with misfolded protein deposits in neurodegenerative diseasesFeizhi Song, Valerija Kovac, Behnam Mohammadi, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Neuron|February 28, 2024
Single-nucleus RNA sequencing demonstrates an autosomal dominant Alzheimer's disease profile and possible mechanisms of disease protectionMaria Camila Almeida, Sarah J Eger, Caroline He, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersVincent Malotaux, David Fernando Aguillón Niño, Isabela Gonzalez, et al.
JAMA|July 30, 2020
Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative DisordersSebastian Palmqvist, Shorena Janelidze, Yakeel T Quiroz, et al.
The American Journal of Pathology|April 24, 2021
Targeting Runt-Related Transcription Factor 1 Prevents Pulmonary Fibrosis and Reduces Expression of Severe Acute Respiratory Syndrome Coronavirus 2 Host MediatorsMichael O'Hare, Dhanesh Amarnani, Hannah A B Whitmore, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 4, 2023
APOE Christchurch-mimetic therapeutic antibody reduces APOE-mediated toxicity and tau phosphorylationClaudia Marino, Paula Perez-Corredor, Michael O'Hare, et al.
The Lancet. Neurology|May 30, 2020
Plasma neurofilament light chain in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional and longitudinal cohort studyYakeel T Quiroz, Henrik Zetterberg, Eric M Reiman, et al.
Acta Neuropathologica|July 15, 2022
Distinct tau neuropathology and cellular profiles of an APOE3 Christchurch homozygote protected against autosomal dominant Alzheimer's dementiaDiego Sepulveda-Falla, Justin S Sanchez, Maria Camila Almeida, et al.
The New England Journal of Medicine|June 20, 2024
<i>APOE3</i> Christchurch Heterozygosity and Autosomal Dominant Alzheimer's DiseaseYakeel T Quiroz, David Aguillon, Daniel C Aguirre-Acevedo, et al.
Stem Cell Reports|January 22, 2022
The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2Susanne Krasemann, Undine Haferkamp, Susanne Pfefferle, et al.
Acta Neuropathologica|July 9, 2024
Cleavage site-directed antibodies reveal the prion protein in humans is shed by ADAM10 at Y226 and associates with misfolded protein deposits in neurodegenerative diseasesFeizhi Song, Valerija Kovac, Behnam Mohammadi, et al.
Pageof 6